Oxalo Therapeutics, Inc.

Biotechnology company · Chicago, Illinois, United States

Oxalo Therapeutics, Inc. is a biotechnology company headquartered in Chicago, Illinois, United States. It has received 2 US government small-business research awards (SBIR/STTR) from health agencies, $2.3 million in total, most recently in 2019.

www.oxalotherapeutics.comProfile compiled from public records. Is this your company? Request a correction or update

Oxalo Therapeutics at a glance

Typebiotechnology company

HeadquartersChicago, Illinois, United States

Employees (self-reported, 2019)1

What does Oxalo Therapeutics do?

US government research funding

2 SBIR/STTR small-business research awards from US health agencies, $2.3 million in total (2018 to 2019). NIH funding came from the National Institute of Diabetes and Digestive and Kidney Diseases.

Frequently asked questions about Oxalo Therapeutics

Where is Oxalo Therapeutics headquartered?

Oxalo Therapeutics, Inc. is headquartered in Chicago, Illinois, United States.

What does Oxalo Therapeutics do?

Oxalo Therapeutics, Inc. is a biotechnology company.

Similar companies

Metame Health Inc.Chicago, Illinois, United States
Synapticure, Inc.Chicago, Illinois, United States
BiomeSense, Inc.Chicago, Illinois, United States
Inomagen Therapeutics, Inc.Chicago, Illinois, United States
Nuago Therapeutics, Inc.Chicago, Illinois, United States
Advanced Cooling Therapy, Inc.Chicago, Illinois, United States
Diagnostic Photonics, Inc.Chicago, Illinois, United States
Microsensor Labs, LLCChicago, Illinois, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences